PCM
CDLX icon

Potomac Capital Management’s Cardlytics CDLX Stock Holding History

Potomac Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,410
Closed -$89.1K – 53
2023
Q2 		$89.1K Sell
1,410
-16,290
-92% -$987K 0.09% 59
2023
Q1 		$601K Buy
+17,700
New +$925K 0.63% 43

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Potomac Capital Management's CDLX Position: Q3 2023 in Review

Potomac Capital Management sold out of Cardlytics (CDLX) in Q3 2023, closing a stake of 1,410 shares — an estimated $89.1K sold.

Potomac Capital Management first reported a position in CDLX in Q1 2023 and held it in 2 quarters. The position peaked at $601K in Q1 2023. 112 funds tracked by Wall St. Rank hold CDLX as of Q3 2023.

  • Potomac Capital Management reported no remaining Cardlytics position as of Q3 2023 after selling out during the quarter.
  • Potomac Capital Management sold 1,410 Cardlytics shares in Q3 2023, an estimated $89.1K.
  • Potomac Capital Management first reported a position in Cardlytics in Q1 2023 and held it in 2 quarters.
  • Potomac Capital Management's Cardlytics position peaked at $601K in Q1 2023.
  • 112 funds tracked by Wall St. Rank held Cardlytics as of Q3 2023.

Based on Potomac Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.